familymednews.com
Patients with pancreatic cancer that hadn’t spread lived substantially longer on a four-drug combo than on a single standard cancer drug, a rare advance for a tough-to-treat disease, researchers reported Monday. The results indicate the powerful chemotherapy treatment known as folfirinox will likely become standard of care for the minority of patients whose pancreatic cancer is diagnosed early enough to […]
Continue reading »
(HealthDay)—No new or unexpected safety issues have been identified in association with diphtheria-tetanus-acellular pertussis (DTaP) vaccines in the United States, according to a study published online June 4 in Pediatrics. Pedro L. Moro, M.D., M.P.H., from the U.S. Centers for Disease Control and Prevention in Atlanta, and colleagues searched the Vaccine Adverse Event Reporting System (VAERS) for U.S. reports of […]
Continue reading »
Early phase clinical trial results presented today at the American Society of Clinical Oncology (ASCO) Annual Meeting 2018 of 258 patients with IDH1+ acute myeloid leukemia (AML) treated with the IDH1 inhibitor ivosidenib show an overall response rate of 41.9 percent, with median progression free survival of 8.2 months. Twenty-four percent of patients achieved a complete response. The gene IDH1 […]
Continue reading »
When the blood supply is low, cancer cells can use lipid molecules as fuel instead of blood glucose. This has been shown in animal tumour models by researchers at Karolinska Institutet, Sweden, in a study published in Cell Metabolism. The mechanism may explain why tumours often develop resistance to cancer drugs that inhibit the formation of blood vessels. Tumour growth […]
Continue reading »
Persistent pain and recurrent episodes of pain are common for those who are living with cancer, or for those undergoing cancer treatment. When used properly, prescription opioids have long been known to help combat pain experienced by people with cancer. In the face of the worsening opioid epidemic, clinical guidelines have been published by multiple agencies to improve the way […]
Continue reading »
A new clinical trial from the University of Leeds is testing omega-3 capsules in patients who have bowel cancer which has spread to the liver, to see if it can stop the cancer returning after surgery. Promising results in an earlier smaller trial showed that providing patients with 2g per day of the omega-3, called EPA, for around a month […]
Continue reading »
Results of a study of nearly 2,000 U.S. citizen children and their mothers add to growing evidence of the multigenerational, beneficial effects of the Deferred Action for Childhood Arrivals (DACA) immigration policy on children who are citizens, illustrating increased participation in the Special Supplemental Nutrition Program for Women, Infants and Children (WIC) among citizen children whose mothers are likely eligible […]
Continue reading »
A Loyola Medicine survey has found that 15.8 percent of adult burn patients screened positive for post-traumatic stress disorder (PTSD). The survey by clinical psychologist Elizabeth Simmons, PsyD, licensed clinical social worker Kelly McElligott, AM, and colleagues from Loyola Medicine’s Burn Center was presented at the annual meeting of the American Burn Association, where it was named the top poster […]
Continue reading »
(HealthDay)—For stable warfarin-treated patients, extended international normalized ratio (INR) testing can be successfully and safely implemented, according to a study published online May 15 in the Journal of Thrombosis and Haemostasis. Geoffrey D. Barnes, M.D., from the University of Michigan in Ann Arbor, and colleagues identified patients as being eligible for extended INR testing based on prior INR value stability […]
Continue reading »
African American infants born prematurely are at higher risk for recurrent wheezing. This condition can cause the baby discomfort and is a risk factor for developing asthma later in life. There are no widely-accepted therapies to prevent prematurity-associated wheezing. In a first-of-its-kind study published in the Journal of the American Medical Association (JAMA), an University Hospitals Rainbow Babies & Children’s […]
Continue reading »